NTLA
Intellia Therapeutics, Inc.
Nasdaq: NTLA · Cambridge, MA
Market Cap$1.29B
Cash$376.0Mmost recent
Runway10 mo$117.3M Q burn
P/E (TTM)—EPS $-3.81
52-Wk Range—
Avg Volume—3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$10.73-59.4%
Pipeline

Drug candidates sponsored by NTLA · ClinicalTrials.gov

Couldn't load pipeline. ClinicalTrials.gov or the backend may be unavailable.
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

Gene editing · 5 tickers
Loading peers…
Cells tinted green are top-ranked in the cohort, red are worst-ranked.